DUHPDimensional US High Profitability ETF$42.56+0.38%
incl. div.
Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.
Institutional holdings are being reconciled with SEC filings. Holder totals and changes may be incomplete until reconciliation finishes.
Holders:65
Total Value:$1,106,251,910
Total Shares:26,496,181
Institutional Ownership Trend
20 quarters
Holder Concentration
Across 65 13F filers
· Δ vs Jun 30, 2026
Top Holder
33.4%
+13.8 pts
Top 5
62.9%
+27.1 pts
Top 10
76.8%
+34.1 pts
HHI
1,511
Moderately concentrated+1,000
Who Holds DUHP
Last 8 quarters through Sep 30, 2026 (filing window open)
Each kind of 13F filer's share of the common shares 13F filers report. Holder type comes from regulatory
records, never the filer's name; style, turnover and horizon are measured from each filer's own 13F book.
The quarter selector does not change this card.
Jun 30, 2026, the newest closed quarter:
561 filers,
like-for-like change +4.5%; actively managed books +4.4%; index-like books +47.4%.
Holder type
Share
Filers
Change
New
Exited
Registered adviser
80.3%
415
+5.4%
32
15
Exempt adviser
0.0%
1
+42.7%
0
0
Adviser
0.0%
2
-30.0%
1
0
Bank
2.9%
15
+1.7%
0
0
Broker-dealer
0.3%
1
+18.0%
0
0
Holding company
0.3%
6
+48.6%
1
0
Unknown
16.1%
121
+0.2%
10
13
Style
Share
Filers
Change
New
Exited
Index-like
0.2%
6
+47.4%
0
0
Systematic-like
0.0%
1
-9.7%
0
2
Concentrated
48.3%
313
+3.1%
14
14
Diversified active
51.5%
240
+5.8%
30
12
Unknown
0.0%
1
0.0%
0
0
Not measured
0.0%
0
—
0
0
Turnover
Share
Filers
Change
New
Exited
Low turnover
88.0%
422
+4.9%
32
13
Medium turnover
5.4%
63
-0.9%
8
6
High turnover
0.2%
5
-34.8%
1
7
Unknown
6.4%
71
+5.5%
3
2
Not measured
0.0%
0
—
0
0
Holding horizon
Share
Filers
Change
New
Exited
Short horizon
4.7%
65
+4.1%
4
4
Medium horizon
19.7%
149
+5.9%
10
10
Long horizon
73.1%
335
+4.3%
29
13
Unknown
2.6%
12
+0.4%
1
1
Not measured
0.0%
0
—
0
0
13F book size
Share
Filers
Change
New
Exited
Under $1B
23.6%
319
+2.1%
17
15
$1B to $10B
29.4%
156
+1.7%
17
11
$10B to $100B
40.9%
59
+7.5%
8
1
$100B or more
6.1%
27
+8.3%
2
1
Not measured
0.0%
0
—
0
0
Client base
Share
Filers
Change
New
Exited
Individuals and high net worth
77.5%
390
+5.5%
29
15
Pooled investment vehicles
0.0%
1
new
1
0
Registered funds and BDCs
0.6%
3
-0.2%
0
0
Pension and profit sharing plans
0.4%
5
-1.6%
1
0
Charitable organizations
0.1%
1
+11.2%
0
0
Other investment advisers
0.1%
6
-9.7%
0
0
Diversified
1.5%
9
+3.4%
1
0
Unknown
19.7%
146
+1.1%
12
13
Private funds
Share
Filers
Change
New
Exited
Hedge funds
0.8%
9
+15.8%
1
0
Private equity funds
1.9%
13
-21.9%
1
0
Venture capital funds
0.0%
2
+0.2%
0
0
Real estate funds
0.3%
9
+12.4%
1
0
Securitized asset funds
0.1%
1
0.0%
0
0
Other private funds
11.3%
13
+4.1%
1
0
Mixed private funds
0.0%
2
+372.0%
1
0
Private funds, type not stated
0.0%
5
+37.2%
0
0
No private funds
65.8%
362
+6.6%
27
15
Unknown
19.6%
145
+1.0%
12
13
Location
Share
Filers
Change
New
Exited
United States
98.0%
554
+4.6%
43
27
Outside the US
2.0%
7
+0.5%
1
1
The Sep 30, 2026 filing window is still open, so its
bar shows only the filers that have filed so far.
How the mix is measured
Shares are 13F common shares restated to today's split basis; options and principal amounts are left out.
The change compares only filers with a 13F in both quarters and keeps each filer in its bucket of the later
quarter on both sides; a filer that continues under a new CIK is compared through its successor. Holder type
comes from each filer's current regulatory profile; client base and private funds come from the Form ADV roster
current at each quarter end (rosters from December 2019, so an earlier quarter reads Unknown). Style, turnover, horizon and
book size are measured from each filer's 13F book in the newest measured quarter, and Not measured means none
was. Actively managed books are those measured systematic-like, concentrated or diversified active.
Excluded 10 holders with no observed 2026-03-31 13F and 7 holders with no observed 2026-06-30 13F.
Conviction and Crowding
561 13F filers, quarter ended Jun 30, 2026
Measured across every 13F filer's common-share book once the quarter's filing window closed. Crowding counts
filers with high turnover or that advise private funds on Form ADV.
Conviction holders
384
68.4% of filers hold it in their top 10
Mar 31, 2026: 378
Holders above 5%
64
median weight 0.229%
Mar 31, 2026: 70
Crowding
—
shares outstanding is an issuer-wide count, not one listing's
Private-fund advisers
—
of shares outstanding
Institutional ownership
—
shares outstanding is an issuer-wide count, not one listing's
Top 10 holders
42.7%
of 13F shares, Herfindahl 0.051
Active holders
+4.4%
like-for-like share change of active filers
5% stakes on record
0
0 13D, 0 13G
How long holders have held itvalue-weighted 12.2 quarters
Under 1 year 6.61%1 to 3 years 34.1%3 years or more 59.3%Since coverage start 0.000%
Managers in the top fifth by current three-year FundScore alpha were net
buyers of $0
(0 buying, 0 selling).
Estimated Holder Cost Basis
Quarter ended Jun 30, 2026, on that quarter's share basis
Estimated, never filed: each 13F buy is costed at its quarter's average traded price and each sale keeps
the average cost, so this is what holders paid on average if they traded evenly through each quarter.
Estimated avg cost
$32.12
estimated per share
Mar 31, 2026: $31.48
Quarter-end price
$41.73
implied by 13F values
Estimated gain or loss
+29.9%
price against the estimated cost
Estimated at a loss
0.000%
of costed 13F value
Estimated cost covers 81.7% of the 13F shares; positions
already held when a filer's 13F history starts, or bought in a quarter without a trusted average price, have no estimate.
Quarterly Activity
vs Jun 30, 2026
New
4
Increased
36
Decreased
19
Sold Out
65
Unchanged
6
New and Sold Out count only filers that reported a 13F for both quarters: a first-time filer's book is not a buy, and a fund that has not filed, or withheld its positions under confidential treatment, has not sold.
